At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BK4583 Monkeypox Concept
Market Closed 12-05 16:00:00 EST
1,659.27
-15.63
-0.93%
High1,674.86Low1,651.43Vol22.25M
Open1,674.86D1 Closing1,674.90Amplitude1.40%
Mkt Cap0.00Tradable Cap0.00Total Shares0.00
T/O1.49BT/O Rate--Tradable Shares0.00
P/B4.140411ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

BRIEF-Kite Announces New Data For Pivotal Immagine-1 Study At Ash 2025, Highlighting Anito-Cel’S Opportunity In Relapsed Or Refractory Multiple Myeloma
Reuters  ·  03:02
BRIEF-Kite Announces New Data For Pivotal Immagine-1 Study At Ash 2025, Highlighting Anito-Cel’S Opportunity In Relapsed Or Refractory Multiple Myeloma
Gilead’s Kite Reports Promising Phase 1 Results for Next-Gen CAR T-Cell Therapies in B-Cell Lymphoma
Reuters  ·  03:00
Gilead’s Kite Reports Promising Phase 1 Results for Next-Gen CAR T-Cell Therapies in B-Cell Lymphoma
Viatris Inc - Viatris to Receive $400 Mln in Cash and $415 Mln in Equity Shares of Biocon Limited
THOMSON REUTERS  ·  12-06 22:00
Viatris Inc - Viatris to Receive $400 Mln in Cash and $415 Mln in Equity Shares of Biocon Limited
Press Release: Viatris Announces Agreement to Monetize its Equity Stake in Biocon Biologics Limited
Dow Jones  ·  12-06 22:00
Press Release: Viatris Announces Agreement to Monetize its Equity Stake in Biocon Biologics Limited
Biocon fully integrates Biocon Biologics in $5.5 billion deal
Reuters  ·  12-06 15:45
Biocon fully integrates Biocon Biologics in $5.5 billion deal
Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
Dow Jones  ·  12-06 06:26
Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
Viatris Appoints David Simmons to Board Committees After Annual Meeting
Reuters  ·  12-06 05:16
Viatris Appoints David Simmons to Board Committees After Annual Meeting
BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EST on 2025-12-05
Reuters  ·  12-06 00:01
BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EST on 2025-12-05
BRIEF-Aethlon Medical Announces Pricing Of A Private Placement And Warrant Inducement
Reuters  ·  12-05 22:15
BRIEF-Aethlon Medical Announces Pricing Of A Private Placement And Warrant Inducement
Press Release: Aethlon Medical Announces Pricing of a Private Placement and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $3.3 Million
Dow Jones  ·  12-05 22:15
Press Release: Aethlon Medical Announces Pricing of a Private Placement and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $3.3 Million
Virax Biolabs Raises $5 Million in Private Placement Sale of Shares
Reuters  ·  12-05 05:15
Virax Biolabs Raises $5 Million in Private Placement Sale of Shares
Virax Biolabs Group Limited Announces Closing of $5 Million Private Placement
THOMSON REUTERS  ·  12-05 05:05
Virax Biolabs Group Limited Announces Closing of $5 Million Private Placement
Press Release: Virax Biolabs Group Limited Announces $5 Million Private Placement
Dow Jones  ·  12-04
Press Release: Virax Biolabs Group Limited Announces $5 Million Private Placement
Crude Oil Gains 1%; Macy's Reports Strong Q3 Results
Benzinga  ·  12-04
Crude Oil Gains 1%; Macy's Reports Strong Q3 Results
Virax Biolabs Highlights Clinical Progress and Outlines 2026 Strategic Priorities
Reuters  ·  12-03
Virax Biolabs Highlights Clinical Progress and Outlines 2026 Strategic Priorities
Aethlon Medical Reports Hemopurifier Removes Inflammatory Extracellular Vesicles in Long COVID Study
Reuters  ·  12-02
Aethlon Medical Reports Hemopurifier Removes Inflammatory Extracellular Vesicles in Long COVID Study
BUZZ-Bavarian Nordic rises on share buyback - 'positive signal' for investors
Reuters  ·  12-02
BUZZ-Bavarian Nordic rises on share buyback - 'positive signal' for investors
Gilead Sciences CEO Daniel O’Day Reports Disposal of Common Shares
Reuters  ·  12-02
Gilead Sciences CEO Daniel O’Day Reports Disposal of Common Shares
Tonix Pharmaceuticals Releases Report on Monoclonal Antibody for Lyme Disease Prevention
Reuters  ·  12-02
Tonix Pharmaceuticals Releases Report on Monoclonal Antibody for Lyme Disease Prevention
Will Tonix Pharmaceuticals Holding (NASDAQ:TNXP) Spend Its Cash Wisely?
Simply Wall St.  ·  12-02
Will Tonix Pharmaceuticals Holding (NASDAQ:TNXP) Spend Its Cash Wisely?

Introduction

Company Name.
BK4583
Affiliated Markets:
Listing Date:
--
Main Business:
Issue price:
--